blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2963116

EP2963116 - TREATMENT OF SIRTUIN 1 (SIRT1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRT 1 [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.09.2021
Database last updated on 13.07.2024
FormerThe patent has been granted
Status updated on  09.10.2020
FormerGrant of patent is intended
Status updated on  04.06.2020
FormerExamination is in progress
Status updated on  26.01.2018
FormerRequest for examination was made
Status updated on  03.11.2016
Most recent event   Tooltip14.06.2024Lapse of the patent in a contracting state
New state(s): TR
published on 17.07.2024 [2024/29]
Applicant(s)For all designated states
CuRNA, Inc.
4400 Biscayne Boulevard
Miami, FL 33137 / US
[2016/01]
Inventor(s)01 / COLLARD, Joseph
1004 Brooks Lane
Delray Beach, Florida 33483 / US
02 / KHORKOVA SHERMAN, Olga
18288 SE Heritage Drive
Tequesta, Florida 33469 / US
03 / COITO, Carlos
4518 Corniche Circle 26
West Palm Beach, Florida 33417 / US
04 / DE LEON, Belinda
720 S. Sapodilla Avenue 305
West Palm Beach, Florida 33401 / US
 [2020/46]
Former [2016/01]01 / COLLARD, Joseph
1004 Brooks Lane
Delray Beach, FL Florida 33483 / US
02 / KHORKOVA SHERMAN, Olga
18288 SE Heritage Drive
Tequesta, FL Florida 33469 / US
03 / COITO, Carlos
4518 Corniche Circle 26
West Palm Beach, FL Florida 33417 / US
04 / DE LEON, Belinda
720 S. Sapodilla Avenue 305
West Palm Beach, FL Florida 33401 / US
Representative(s)Mathys & Squire
The Shard
32 London Bridge Street
London SE1 9SG / GB
[2020/46]
Former [2016/01]Evenson, Jane Harriet, et al
Mathys & Squire LLP The Shard
32 London Bridge Street
London SE1 9SG / GB
Application number, filing date15180416.803.03.2010
[2016/01]
Priority number, dateUS20090157255P04.03.2009         Original published format: US 157255 P
US20090259072P06.11.2009         Original published format: US 259072 P
WO2009US6644502.12.2009         Original published format: PCT/US2009/066445
[2016/01]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2963116
Date:06.01.2016
Language:EN
[2016/01]
Type: A3 Search report 
No.:EP2963116
Date:23.03.2016
Language:EN
[2016/12]
Type: B1 Patent specification 
No.:EP2963116
Date:11.11.2020
Language:EN
[2020/46]
Search report(s)(Supplementary) European search report - dispatched on:EP22.02.2016
ClassificationIPC:C12N15/63, C12N15/11, C07H19/00, C12Q1/68
[2016/01]
CPC:
C12N15/1137 (EP,US); A61P1/00 (EP); A61P1/04 (EP);
A61P1/16 (EP); A61P11/00 (EP); A61P13/00 (EP);
A61P13/08 (EP); A61P13/12 (EP); A61P15/00 (EP);
A61P17/00 (EP); A61P19/00 (EP); A61P19/02 (EP);
A61P19/04 (EP); A61P19/10 (EP); A61P21/00 (EP);
A61P25/00 (EP); A61P25/14 (EP); A61P25/16 (EP);
A61P25/28 (EP); A61P25/32 (EP); A61P27/02 (EP);
A61P29/00 (EP); A61P3/00 (EP); A61P3/04 (EP);
A61P3/06 (EP); A61P3/08 (EP); A61P3/10 (EP);
A61P31/14 (EP); A61P31/18 (EP); A61P35/00 (EP);
A61P35/02 (EP); A61P43/00 (EP); A61P5/50 (EP);
A61P7/00 (EP); A61P9/00 (EP); A61P9/04 (EP);
A61P9/10 (EP); C12Y305/01098 (EP,US); C12N2310/11 (EP,US);
C12N2310/113 (EP,US); C12N2310/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2016/01]
TitleGerman:BEHANDLUNG VON SIRTUIN 1 (SIRT1)-BEDINGTEN ERKRANKUNGEN MITTELS HEMMUNG DES NATÜRLICHEN ANTISENSE-TRANSKRIPTS GEGEN SIRT 1[2016/01]
English:TREATMENT OF SIRTUIN 1 (SIRT1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRT 1[2016/01]
French:TRAITEMENT DE SIRTUINE 1 (SIRT1) ASSOCIÉE À DES MALADIES PAR INHIBITION DU TRANSCRIT ANTISENS NATUREL DE SIRT 1[2016/01]
Examination procedure10.08.2015Examination requested  [2016/01]
11.01.2017Amendment by applicant (claims and/or description)
01.02.2018Despatch of a communication from the examining division (Time limit: M08)
08.11.2018Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
07.01.2019Reply to a communication from the examining division
24.04.2019Despatch of a communication from the examining division (Time limit: M06)
24.10.2019Reply to a communication from the examining division
05.06.2020Communication of intention to grant the patent
05.10.2020Fee for grant paid
05.10.2020Fee for publishing/printing paid
05.10.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP10749298.5  / EP2403946
Opposition(s)12.08.2021No opposition filed within time limit [2021/42]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
07.01.2019Request for further processing filed
07.01.2019Full payment received (date of receipt of payment)
Request granted
22.01.2019Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
11.01.2017Request for further processing filed
11.01.2017Full payment received (date of receipt of payment)
Request granted
27.01.2017Decision despatched
Fees paidRenewal fee
10.08.2015Renewal fee patent year 03
10.08.2015Renewal fee patent year 04
10.08.2015Renewal fee patent year 05
10.08.2015Renewal fee patent year 06
31.03.2016Renewal fee patent year 07
27.03.2017Renewal fee patent year 08
27.03.2018Renewal fee patent year 09
27.03.2019Renewal fee patent year 10
27.03.2020Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.03.2010
AT11.11.2020
CY11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
MK11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
SE11.11.2020
SI11.11.2020
SK11.11.2020
SM11.11.2020
TR11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
LU03.03.2021
IS11.03.2021
PT11.03.2021
BE31.03.2021
CH31.03.2021
LI31.03.2021
[2024/29]
Former [2024/22]HU03.03.2010
AT11.11.2020
CY11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
MK11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
SE11.11.2020
SI11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
LU03.03.2021
IS11.03.2021
PT11.03.2021
BE31.03.2021
CH31.03.2021
LI31.03.2021
Former [2023/27]HU03.03.2010
AT11.11.2020
CY11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
SE11.11.2020
SI11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
LU03.03.2021
IS11.03.2021
PT11.03.2021
BE31.03.2021
CH31.03.2021
LI31.03.2021
Former [2023/24]AT11.11.2020
CY11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
SE11.11.2020
SI11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
LU03.03.2021
IS11.03.2021
PT11.03.2021
BE31.03.2021
CH31.03.2021
LI31.03.2021
Former [2022/34]AT11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
SE11.11.2020
SI11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
LU03.03.2021
IS11.03.2021
PT11.03.2021
BE31.03.2021
CH31.03.2021
LI31.03.2021
Former [2022/23]AT11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
SE11.11.2020
SI11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
LU03.03.2021
IS11.03.2021
PT11.03.2021
CH31.03.2021
LI31.03.2021
Former [2022/10]AT11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
SE11.11.2020
SI11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
LU03.03.2021
PT11.03.2021
CH31.03.2021
LI31.03.2021
Former [2022/09]AT11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
SE11.11.2020
SI11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
LU03.03.2021
IS11.03.2021
PT11.03.2021
Former [2021/50]AT11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
SE11.11.2020
SI11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/46]AT11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
SE11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/45]AT11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
PL11.11.2020
RO11.11.2020
SE11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/37]AT11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
PL11.11.2020
RO11.11.2020
SE11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/36]AT11.11.2020
CZ11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
PL11.11.2020
RO11.11.2020
SE11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/35]AT11.11.2020
CZ11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
PL11.11.2020
RO11.11.2020
SE11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/34]AT11.11.2020
CZ11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
PL11.11.2020
SE11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/33]AT11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
PL11.11.2020
SE11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/32]AT11.11.2020
FI11.11.2020
HR11.11.2020
LV11.11.2020
PL11.11.2020
SE11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/28]AT11.11.2020
FI11.11.2020
HR11.11.2020
LV11.11.2020
PL11.11.2020
SE11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/25]AT11.11.2020
FI11.11.2020
LV11.11.2020
PL11.11.2020
SE11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/24]AT11.11.2020
FI11.11.2020
LV11.11.2020
SE11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
PT11.03.2021
Former [2021/23]FI11.11.2020
LV11.11.2020
SE11.11.2020
NO11.02.2021
GR12.02.2021
PT11.03.2021
Former [2021/22]FI11.11.2020
NO11.02.2021
PT11.03.2021
Former [2021/21]FI11.11.2020
PT11.03.2021
Former [2021/20]FI11.11.2020
Documents cited:Search[E]WO2010065662  (CURNA INC [US], et al) [E] 1-14 * claims 3,16-18,24 *;
 [A]  - KUEHBACHER ANGELIKA ET AL, "MicroRNA 92a Controls Vessel Growth And Functional Recovery After Ischemia", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (200810), Database accession no. PREV200900197869, XP002684082 [A] 1-14 * abstract *
 [AP]  - BONAUER ANGELIKA ET AL, "MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, (20090626), vol. 324, no. 5935, ISSN 0036-8075, pages 1710 - 1713, XP002575234 [AP] 1-14 * page 1711 *
 [A]  - SUN ET AL, "Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells", LUNG CANCER, ELSEVIER, AMSTERDAM, NL, (20070914), vol. 58, no. 1, doi:10.1016/J.LUNGCAN.2007.05.013, ISSN 0169-5002, pages 21 - 29, XP022242948 [A] 1-14 * page 23 *

DOI:   http://dx.doi.org/10.1016/j.lungcan.2007.05.013
 [A]  - WAHLESTEDT ET AL, "Natural antisense and noncoding RNA transcripts as potential drug targets", DRUG DISCOVERY TODAY, ELSEVIER, RAHWAY, NJ, US, vol. 11, no. 11-12, ISSN 1359-6446, (20060601), pages 503 - 508, (20060601), XP027889295 [A] 1-14 * page 505 *
 [A]  - MUNEKAZU YAMAKUCHI ET AL, "miR-34a repression of SIRT1 regulates apoptosis", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 105, no. 36, doi:10.1073/PNAS.0801613105, ISSN 0027-8424, (20080909), pages 13421 - 13426, (20080828), XP008149911 [A] 1-14 * page 13421 *

DOI:   http://dx.doi.org/10.1073/pnas.0801613105
 [A]  - SMALHEISER N R ET AL, "Natural antisense transcripts are co-expressed with sense mRNAs in synaptoneurosomes of adult mouse forebrain", NEUROSCIENCE RESEARCH, ELSEVIER, SHANNON, IR, vol. 62, no. 4, doi:10.1016/J.NEURES.2008.08.010, ISSN 0168-0102, (20081201), pages 236 - 239, (20080904), XP025669354 [A] 1-14 * page 238 *

DOI:   http://dx.doi.org/10.1016/j.neures.2008.08.010
 [A]  - THIMMAPPA S. ANEKONDA ET AL, "Neuronal protection by sirtuins in Alzheimer's disease", JOURNAL OF NEUROCHEMISTRY, (20060101), vol. 96, no. 2, doi:10.1111/j.1471-4159.2005.03492.x, ISSN 0022-3042, pages 305 - 313, XP055039113 [A] 1-14 * page 307 *

DOI:   http://dx.doi.org/10.1111/j.1471-4159.2005.03492.x
 [A]  - "Mus musculus 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030437B01 product:synembryn, full insert sequence.", ENA, (20080923), Database accession no. AK031466, URL: EBI, XP002745421 [A] 1-14 * sequence . *
 [I]  - "xj35b03.x1 Soares_NFL_T_GBC_S1 Homo sapiens cDNA clone IMAGE:2659181 3', mRNA sequence.", ENA, (20000304), Database accession no. AW169958, URL: EBI, XP002745422 [I] 1-14 * sequence . *
 [AP]  - APARNA PURUSHOTHAM ET AL, "Hepatocyte-Specific Deletion of SIRT1 Alters Fatty Acid Metabolism and Results in Hepatic Steatosis and Inflammation", CELL METABOLISM, (20090408), vol. 9, no. 4, doi:10.1016/j.cmet.2009.02.006, ISSN 1550-4131, pages 327 - 338, XP055039151 [AP] 1-14 * page 328 *

DOI:   http://dx.doi.org/10.1016/j.cmet.2009.02.006
Examination   - "Mus musculus adult retina cDNA, RIKEN full-length enriched library, clone:A930026H04 product:hypothetical protein, full insert sequence.", EMBL, (20080923), Database accession no. AK044604, URL: EBI
    - L R Saunders ET AL, "Sirtuins: critical regulators at the crossroads between cancer and aging", ONCOGENE, (20070801), vol. 26, no. 37, doi:10.1038/sj.onc.1210616, ISSN 0950-9232, pages 5489 - 5504, XP055439842

DOI:   http://dx.doi.org/10.1038/sj.onc.1210616
by applicantUS5432272
 US7544497
 US5013830
 US5149797
 US5220007
 US5256775
 US5366878
 US5403711
 US5491133
 US5565350
 US5623065
 US5652355
 US5652356
 US5700922
 US5034506
 US5138045
 US5218105
 US5459255
 US3687808
 US4469863
 US4476301
 US5023243
 US5177196
 US5188897
 US5264423
 US5276019
 US5278302
 US5286717
 US5321131
 US5399676
 US5405939
 US5453496
 US5455233
 US5466677
 US5476925
 US5519126
 US5536821
 US5541306
 US5550111
 US5563253
 US5571799
 US5587361
 US5625050
 US5166315
 US5185444
 US5214134
 US5216141
 US5235033
 US5264562
 US5264564
 US5405938
 US5434257
 US5470967
 US5489677
 US5541307
 US5561225
 US5596086
 US5602240
 US5610289
 US5608046
 US5618704
 US5623070
 US5663312
 US5633360
 US5677437
 US5677439
 US5539082
 US5714331
 US5719262
 US4981957
 US5118800
 US5319080
 US5359044
 US5393878
 US5446137
 US5466786
 US5514785
 US5519134
 US5567811
 US5576427
 US5591722
 US5597909
 US5610300
 US5627053
 US5639873
 US5646265
 US5658873
 US5670633
 US5700920
 US4845205
 US5130302
 US5134066
 US5175273
 US5367066
 US5457187
 US5484908
 US5502177
 US5525711
 US5552540
 US5587469
 US5596091
 US5614617
 US5750692
 US5681941
 US4828979
 US4948882
 US5525465
 US5541313
 US5545730
 US5552538
 US5578717
 US5580731
 US5591584
 US5109124
 US5118802
 US5414077
 US5486603
 US5512439
 US5578718
 US4587044
 US4605735
 US4667025
 US4762779
 US4789737
 US4824941
 US4835263
 US4876335
 US4904582
 US4958013
 US5082830
 US5112963
 US5214136
 US5245022
 US5254469
 US5258506
 US5262536
 US5272250
 US5292873
 US5317098
 US5371241
 US5391723
 US5416203
 US5451463
 US5510475
 US5512667
 US5565552
 US5567810
 US5574142
 US5585481
 US5587371
 US5595726
 US5597696
 US5599923
 US5599928
 US5688941
 US6287860
 US5108921
 US5354844
 US5416016
 US5459127
 US5521291
 US5543165
 US5547932
 US5583020
 US5591721
 US4426330
 US4534899
 US5013556
 US5213804
 US5227170
 US5264221
 US5356633
 US5395619
 US5417978
 US5462854
 US5469854
 US5512295
 US5527528
 US5534259
 US5543152
 US5556948
 US5580575
 US5595756
 US2007117772
 US6632427
 US6756523
 US4866042
 US6294520
 US6936589
 US7563884
    - EGUCHI ET AL., ANN. REV. BIOCHEM., (1991), vol. 60, pages 631 - 652
    - CAPLEN, N. J. ET AL., PROC. NATL. ACAD. SCI. USA, (2001), vol. 98, pages 9742 - 9747
    - BERNSTEIN, E. ET AL., NATURE, (2001), vol. 409, pages 363 - 366
    - BOUTLA, A. ET AL., CURR. BIOL., (2001), vol. 11, pages 1776 - 1780
    - CECH, J. AMERICAN. MED. ASSOC., (1988), vol. 260, pages 3030 - 3035
    - SULLENGER ET AL., CELL, (1990), vol. 63, pages 601 - 608
    - FREIER; ALTMANN, NUCL. ACID. RES., (1997), vol. 25, no. 22, pages 4429 - 4443
    - TOULME, J.J., NATURE BIOTECHNOLOGY, (2001), vol. 19, pages 17 - 18
    - MANOHARAN M., BIOCHEMICA ET BIOPHYSICA ACTA, (1999), vol. 1489, pages 117 - 139
    - FREIER S. M., NUCLEIC ACID RESEARCH, (1997), vol. 25, pages 4429 - 4443
    - UHLMAN, E., DRUG DISCOVERY & DEVELOPMENT, (2000), vol. 3, pages 203 - 213
    - HERDEWIN P., ANTISENSE & NUCLEIC ACID DRUG DEV., (2000), vol. 10, pages 297 - 310
    - N.K CHRISTIENSEN. ET AL., J. AM. CHEM. SOC., (1998), vol. 120, pages 5458 - 5463
    - PRAKASH TP; BHAT B., CURR TOP MED CHEM., (2007), vol. 7, no. 7, pages 641 - 9
    - CHO EJ, ANNUAL REVIEW OF ANALYTICAL CHEMISTRY, (2009), vol. 2, pages 241 - 264
    - ALTSCHUL ET AL., J. MOL. BIOL., (1990), vol. 215, pages 403 - 410
    - ZHANG; MADDEN, GENOME RES., (1997), vol. 7, pages 649 - 656
    - SMITH; WATERMAN, ADV. APPL. MATH., (1981), vol. 2, pages 482 - 489
    - BATEMAN A ET AL., "The Pfam Protein Families Database", NUCLEIC ACIDS RESEARCH, (2002), vol. 30, no. 1, pages 276 - 280
    - SONHAMMER ET AL., PROTEINS, (1997), vol. 28, no. 3, pages 405 - 420
    - GRIBSKOV ET AL., METH. ENZYMOL., (1990), vol. 183, pages 146 - 159
    - GRIBSKOV ET AL., PROC. NATL. ACAD. SCI. USA, (1987), vol. 84, pages 4355 - 4358
    - KROGH, J. MOL. BIOL., (1994), vol. 235, pages 1501 - 1531
    - STULTZ ET AL., PROTEIN SCI., (1993), vol. 2, pages 305 - 314
    - HAN SH, J CLIN NEUROL., (2009), vol. 5, no. 3, pages 120 - 5
    - MICHAN S ET AL., BIOCHEM J., (2007), vol. 404, no. 1, pages 1 - 13
    - FISCHER LR ET AL., EXP NEURO/, (2004), vol. 185, pages 232 - 240
    - STOKIN GB ET AL., SCIENCE, (2005), vol. 307, pages 1282 - 1288
    - YAMAMOTO H ET AL., MOL ENDOCRINOL, (2007), vol. 21, no. 8, pages 1745 - 1755
    - CHENG, J. ET AL., SCIENCE, (2005), vol. 308, no. 5725, pages 1149 - 1154
    - KAPRANOV, P. ET AL., GENOME RES, (2005), vol. 15, no. 7, pages 987 - 997
    - FIRE ET AL., NATURE, (1998), vol. 391, pages 806 - 811
    - TIMMONS; FIRE, NATURE, (1998), vol. 395, page 854
    - TIMMONS ET AL., GENE, (2001), vol. 263, pages 103 - 112
    - TABARA ET AL., SCIENCE, (1998), vol. 282, pages 430 - 431
    - MONTGOMERY ET AL., PROC. NATL. ACAD. SCI. USA, (1998), vol. 95, pages 15502 - 15507
    - TUSCHL ET AL., GENES DEV., (1999), vol. 13, pages 3191 - 3197
    - ELBASHIR ET AL., NATURE, (2001), vol. 411, pages 494 - 498
    - ELBASHIR ET AL., GENES DEV., (2001), vol. 15, pages 188 - 200
    - TIJSTERMAN ET AL., SCIENCE, (2002), vol. 295, pages 694 - 697
    - ZAUG ET AL., NATURE, (1986), vol. 324, page 429
    - CECH, JAMA, (1988), vol. 260, page 3030
    - JEFFERIES ET AL., NUCLEIC ACIDS RESEARCH, (1989), vol. 17, page 1371
    - USMAN; MCSWIGGEN, ANN. REP. MED. CHEM., (1995), vol. 30, pages 285 - 294
    - CHRISTOFFERSEN; MARR, J. MED. CHEM., (1995), vol. 38, pages 2023 - 2037
    - ORGEL, PROC. R. SOC. LONDON, (1979), vol. 205, page 435
    - JOYCE, GENE, (1989), vol. 82, pages 83 - 87
    - BEAUDRY ET AL., SCIENCE, (1992), vol. 257, pages 635 - 641
    - JOYCE, SCIENTIFIC AMERICAN, (1992), vol. 267, pages 90 - 97
    - BREAKER ET AL., TIBTECH, (1994), vol. 12, page 268
    - BARTEL ET AL., SCIENCE, (1993), vol. 261, pages 1411 - 1418
    - SZOSTAK, TIBS, (1993), vol. 17, pages 89 - 93
    - KUMAR ET AL., FASEB J., (1995), vol. 9, page 1183
    - BREAKER, CURR. OP. BIOTECH., (1996), vol. 7, page 442
    - UHLENBECK, O. C., NATURE, (1987), vol. 328, pages 596 - 600
    - HASELOFF; GERLACH, NATURE, (1988), vol. 334, page 585
    - WALBOT; BRUENING, NATURE, (1988), vol. 334, page 196
    - KOIZUMI, M. ET AL., FEBS LETT., (1988), vol. 228, pages 228 - 230
    - HAMMOND ET AL., NAT. REV. GENET., (1991), vol. 2, pages 110 - 119
    - MATZKE ET AL., CURR. OPIN. GENET. DEV., (2001), vol. 11, pages 221 - 227
    - SHARP, GENES DEV., (2001), vol. 15, pages 485 - 490
    - FU ET AL., "Hormonal Control of Androgen Receptor Function through SIRTl", MOLECULAR AND CELLULAR BIOLOGY, (2006), vol. 26, no. 21, pages 8122 - 8135
    - Encyclopedia of Pharmaceutical Technology, NEW YORK: MARCEL DEKKER, (1992), vol. 9
    - DE MESMAEKER ET AL., ACC. CHEM. RES., (1995), vol. 28, pages 366 - 374
    - NIELSEN ET AL., SCIENCE, (1991), vol. 254, page 1497
    - MARTIN ET AL., HELV. CHIM. ACTA, (1995), vol. 78, page 486
    - KORNBERG, A., DNA Replication, W. H. FREEMAN & CO., (1980), pages 75 - 77
    - GEBEYEHU, G. ET AL., NUCL. ACIDS RES., (1987), vol. 15, page 4513
    - Antisense Research and Applications, CRC PRESS, (1993), pages 276 - 278
    - LETSINGER ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, page 6553
    - MANOHARAN ET AL., BIOORG. MED. CHEM. LET., (1994), vol. 4, page 1053
    - MANOHARAN ET AL., ANN. N.Y. ACAD. SCI., (1992), vol. 660, page 306
    - MANOHARAN ET AL., BIOORG. MED. CHEM. LET., (1993), vol. 3, page 2765
    - OBERHAUSER ET AL., NUCL. ACIDS RES., (1992), vol. 20, page 533
    - SAISON-BEHMOARAS ET AL., EMBO J., (1991), vol. 10, page 111
    - KABANOV ET AL., FEBS LETT., (1990), vol. 259, page 327
    - SVINARCHUK ET AL., BIOCHIMIE, (1993), vol. 75, page 49
    - MANOHARAN ET AL., TETRAHEDRON LETT., (1995), vol. 36, page 3651
    - SHEA ET AL., NUCL. ACIDS RES., (1990), vol. 18, page 3777
    - MANOHARAN ET AL., NUCLEOSIDES & NUCLEOTIDES, (1995), vol. 14, page 969
    - UHLMAN ET AL., CURRENT OPINIONS IN DRUG DISCOVERY & DEVELOPMENT, (2000), vol. 3, no. 2
    - NIELSEN ET AL., SCIENCE, (1991), vol. 254, pages 1497 - 1500
    - MARTIN ET AL., HELV. CHIM. ACTA, (1995), vol. 78, pages 486 - 504
    - The Concise Encyclopedia of Polymer Science And Engineering, JOHN WILEY & SONS, (1990), pages 858 - 859
    - ENGLISCH ET AL., ANGEWANDLE CHEMIE, INTERNATIONAL EDITION, (1991), vol. 30, page 613
    - SANGHVI, Y.S.; CROOKE, S.T.; LEBLEU, B. EA., Antisense Research and Applications, CRC PRESS, (1993), pages 289 - 302
    - LETSINGER ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 6553 - 6556
    - MANOHARAN ET AL., BIOORG. MED. CHEM. LET., (1994), vol. 4, pages 1053 - 1060
    - MANOHARAN ET AL., ANN. N. Y ACAD. SCI., (1992), vol. 660, pages 306 - 309
    - MANOHARAN ET AL., BIOORG. MED. CHEM. LET., (1993), vol. 3, pages 2765 - 2770
    - OBERHAUSER ET AL., NUCL. ACIDS RES., (1992), vol. 20, pages 533 - 538
    - KABANOV ET AL., FEBS LETT., (1990), vol. 259, pages 327 - 330
    - SVINARCHUK ET AL., BIOCHIMIE, (1993), vol. 75, pages 49 - 54
    - MANOHARAN ET AL., TETRAHEDRON LETT., (1995), vol. 36, pages 3651 - 3654
    - SHEA ET AL., NUCL. ACIDS RES., (1990), vol. 18, pages 3777 - 3783
    - MANCHARAN ET AL., NUCLEOSIDES & NUCLEOTIDES, (1995), vol. 14, pages 969 - 973
    - MISHRA ET AL., BIOCHIM. BIOPHYS. ACTA, (1995), vol. 1264, pages 229 - 237
    - CROOKE ET AL., J. PHARMACOL. EXP. THER., (1996), vol. 277, pages 923 - 937
    - BRAZMA; VILO, FEBS LETT., (2000), vol. 480, pages 17 - 24
    - CELIS ET AL., FEBS LETT., (2000), vol. 480, pages 2 - 16
    - MADDEN ET AL., DRUG DISCOV. TODAY, (2000), vol. 5, pages 415 - 425
    - PRASHAR; WEISSMAN, METHODS ENZYMOL., (1999), vol. 303, pages 258 - 72
    - SUTCLIFFE ET AL., PROC. NATL. ACAD. SCI. U.S.A., (2000), vol. 97, pages 1976 - 81
    - JUNGBLUT ET AL., ELECTROPHORESIS, (1999), vol. 20, pages 2100 - 10
    - LARSSON ET AL., J. BIOTECHNOL., (2000), vol. 80, pages 143 - 57
    - FUCHS ET AL., ANAL. BIOCHEM., (2000), vol. 286, pages 91 - 98
    - LARSON ET AL., CYTOMETRY, (2000), vol. 41, pages 203 - 208
    - JURECIC; BELMONT, CURR. OPIN. MICROBIOL., (2000), vol. 3, pages 316 - 21
    - CARULLI ET AL., J. CELL BIOCHEM. SUPPL., (1998), vol. 31, pages 286 - 96
    - GOING; GUSTERSON, EUR. J. CANCER, (1999), vol. 35, pages 1895 - 904
    - TO, COMB., CHEM. HIGH THROUGHPUT SCREEN, (2000), vol. 3, pages 235 - 41
    - GELLER, A.I. ET AL., J. NEUROCHEM, (1995), vol. 64, page 487
    - GELLER, A.I. ET AL., PROC NATL. ACAD. SCI.: U.S.A., (1993), vol. 90, page 7603
    - GELLER, A.I. ET AL., PROC NATL. ACAD. SCI USA, (1990), vol. 87, page 1149
    - LEGAL LASALLE ET AL., SCIENCE, (1993), vol. 259, page 988
    - DAVIDSON ET AL., NAT. GENET., (1993), vol. 3, page 219
    - YANG ET AL., J. VIROL., (1995), vol. 69, page 2004
    - KAPLITT, M.G. ET AL., NAT. GENET., (1994), vol. 8, page 148
    - PURUSHOTHAM A. ET AL., CELL METABOLISM, (2009), vol. 9, pages 327 - 338
 WO1992US09196
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.